HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE.

AbstractOBJECTIVE:
Observational data suggest a potential for subclinical cardiac damage from intensive blood glucose or blood pressure (BP) control, particularly in adults with very low blood glucose and BP levels. However, this has not been tested in a randomized trial.
METHODS:
The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Research Controlled Evaluation (ADVANCE) study was a factorial, randomized trial designed to test the effects of intensive blood glucose (hemoglobin A1c ≤6.5% versus usual care) and intensive BP (combination of perindopril-indapamide versus placebo) control on vascular events in adults with diabetes. Using mixed effects tobit models, we determined the effect of the randomized interventions on change in subclinical cardiac injury (high sensitivity cardiac troponin T [hs-cTnT]) and strain (N-terminal b-type pro natriuretic peptide [NT-proBNP]), 1 year after randomization.
RESULTS:
Among the 682 participants, mean age was 66.1 (SD, 6.5) years; 40% were women. Mean baseline hemoglobin A1c was 7.4% (SD, 1.5) and systolic/diastolic BP was 147 (SD,21)/81 (SD,11) mmHg. After 1 year, intensive versus standard glucose control did not significantly change hs-cTnT (1.5%; 95%CI:-4.9,8.2) or NT-proBNP (-10.3%; 95%CI: -20.2%,0.9%). Intensive versus standard BP control also did not affect hs-cTnT (-2.9%; 95%CI: -8.9,3.6), but did significantly lower NT-proBNP by 21.6% (95%CI:-30.2%,-11.9%). Changes in systolic BP at 1 year (versus baseline) were strongly associated with NT-proBNP (P = 0.004), but not hs-cTnT (P = 0.95).
CONCLUSIONS:
In adults with diabetes, intensive BP control reduced NT-proBNP without increasing hs-cTnT, supporting the benefits and safety of intensive BP control in adults with diabetes. This trial is registered at clinicaltrials.gov, number: NCT00145925.
AuthorsStephen P Juraschek, Dan Wang, John W McEvoy, Stephen Harrap, Katie Harris, Giuseppe Mancia, Michel Marre, Bruce Neal, Anushka Patel, Neil R Poulter, Bryan Williams, John Chalmers, Mark Woodward, Elizabeth Selvin
JournalInternational journal of cardiology (Int J Cardiol) Vol. 358 Pg. 103-109 (07 01 2022) ISSN: 1874-1754 [Electronic] Netherlands
PMID35439582 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2022 Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers
  • Blood Glucose
  • Glycated Hemoglobin A
  • Peptide Fragments
  • Troponin T
  • Natriuretic Peptide, Brain
  • Glucose
Topics
  • Aged
  • Biomarkers
  • Blood Glucose
  • Blood Pressure
  • Female
  • Glucose
  • Glycated Hemoglobin
  • Humans
  • Hypotension
  • Male
  • Middle Aged
  • Natriuretic Peptide, Brain
  • Peptide Fragments
  • Troponin T

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: